Top Markets
#1 Black Phoenix Black Phoenix +166.36%
#2 Islamic Coin Islamic Coin +158.10%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +37.67%
#5 Cryptopia Cryptopia +21.67%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +19.21%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.34%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.75%
#9 DOVU DOVU +13.78%
#10 OVERTAKE OVERTAKE +11.88%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Rang in aandelen #41543
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$16.73K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel ARYx Therapeutics, Inc. (ARYX)

Categorie

Healthcare
Dividendgeschiedenis van ARYx Therapeutics, Inc. (ARYX)
ARYx Therapeutics, Inc. (aandelsymbool: ARYX) heeft in totaal 0 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: 0.00
Dividendrendement (TTM): 0
Dividendbetalingen voor ARYx Therapeutics, Inc. (ARYX) van 2026 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
38.00%
IN